• Sildenafil Citrate: Proteoform-Specific Assay Design in Vasc

  2026-06-19

  Explore how Sildenafil Citrate, a cGMP-specific phosphodiesterase type 5 inhibitor, enables next-generation proteoform-specific assay development. This article uniquely bridges membrane proteomics with practical workflow design, offering advanced insights for vascular biology research.

• S Tag Peptide: Technical Guidance for Fusion Tag Workflows

  2026-06-18

  S Tag Peptide (A6007) provides a reliable solution for improving solubility, detection, and purification of recombinant proteins through fusion tag workflows. It is not suitable for use in ethanol-based applications or as an active enzyme fragment alone, making it ideal for affinity-based detection and purification in aqueous systems.

• Disrupting SARS-CoV-2 Nucleocapsid LLPS: Mechanistic Insight

  2026-06-18

  Zhao et al. reveal that the SARS-CoV-2 nucleocapsid (N) protein undergoes RNA-driven liquid–liquid phase separation (LLPS), a process essential for viral replication and assembly. Importantly, they demonstrate that (-)-gallocatechin gallate (GCG) disrupts this phase separation and inhibits viral replication, providing a new mechanistic target for antiviral intervention.

• Balancing Organoid Fate: CHIR 99021 Trihydrochloride in Tran

  2026-06-17

  An in-depth, evidence-based analysis of how CHIR 99021 trihydrochloride empowers translational researchers to precisely modulate the balance between stem cell self-renewal and differentiation in organoid systems. This article integrates mechanistic insights, protocol guidance, and strategic perspectives to advance the frontiers of disease modeling, metabolic research, and high-throughput screening.

• Resibufogenin Blocks NLRP3 Inflammasome to Alleviate Atheros

  2026-06-17

  This study demonstrates that resibufogenin (RBG) effectively inhibits the NLRP3 inflammasome, leading to reduced inflammation, lipid accumulation, and fibrosis in an ApoE-/- mouse model of atherosclerosis. The findings highlight RBG’s potential as a targeted therapeutic for cardiovascular disease and provide mechanistic insight into inflammasome-driven pathology.

• ALDH2 Activation Delays Heart Failure by Promoting Cardiac R

  2026-06-16

  The reference study demonstrates that activating ALDH2, including via Alda 1, significantly enhances cardiomyocyte proliferation and delays pressure overload-induced heart failure in mice. These findings identify ALDH2 as a promising target for cardiac regeneration, with direct implications for ischemia and heart failure research.

• Captopril: ACE Inhibitor Workflows for Translational Researc

  2026-06-16

  Captopril, a gold-standard ACE inhibitor, powers high-fidelity translational research from hypertension to oncology. Explore advanced experimental workflows, protocol enhancements, and troubleshooting strategies that leverage its unique mechanistic specificity and purity for reproducible results.

• Oligomycin A: Advanced Insights into Mitochondrial ATP Synth

  2026-06-15

  Explore the unique role of Oligomycin A as a mitochondrial ATP synthase inhibitor in dissecting cellular energy metabolism and cancer adaptation. This article delivers in-depth, evidence-based analysis and practical assay guidance beyond existing summaries.

• SARS-CoV-2 N Protein Impairs GADD34-IRF3 Immunity via Atypic

  2026-06-15

  Liu et al. (2024) delineate a novel immune evasion strategy by which the SARS-CoV-2 nucleocapsid protein sequesters GADD34 mRNA in atypical stress granule-like foci. This mechanism disrupts IRF3 nuclear translocation and interferon gene activation, advancing our understanding of viral pathogenesis and providing a molecular basis for targeted antiviral research.

• Comparative In Vitro Activity of Sisomicin and Tobramycin

  2026-06-14

  Stewart and Bodey's study rigorously compared the in vitro antibacterial activity of sisomicin, a novel aminoglycoside, with established agents like tobramycin and gentamicin across a large panel of clinical isolates. Their findings clarify spectrum, potency, and cross-resistance among aminoglycosides, offering valuable guidance for microbiology research and experimental antibiotic selection.

• Neuroligin 1 Loss Drives Repetitive Behaviors via PKC Hypera

  2026-06-13

  This study uncovers how loss of Neuroligin 1 in striatal D2-MSNs leads to excessive repetitive behaviors, a hallmark of autism spectrum disorder, by inducing protein kinase C (PKC) overactivation. The findings clarify cell-type-specific circuit mechanisms underlying restricted and repetitive behaviors and highlight PKC as a potential molecular intervention point.

• Quadruple Knockout CHO Cells Enable Extended Fed-Batch Cultu

  2026-06-12

  This study presents a CHO cell line engineered via CRISPR/Cas9 to knock out four genes—bak1, bax, glul, and dhfr—while overexpressing bcl-2 and beclin-1. The resulting cells demonstrate robust apoptosis resistance and enhanced suitability for metabolic selection and long-duration fed-batch culture, advancing biopharmaceutical cell line engineering.

• Azilsartan Medoxomil Monopotassium in Hypertension Research

  2026-06-12

  Azilsartan medoxomil monopotassium (TAK 491) offers unmatched selectivity and sustained receptor affinity, making it a top-tier tool for essential hypertension and cardiovascular disease research. This article details practical workflows, comparative advantages, and troubleshooting strategies for maximizing experimental reliability with this potent angiotensin II receptor blocker.

• Phase 2 Evaluation of Gepotidacin for Urogenital Gonorrhea T

  2026-06-11

  This phase 2 study demonstrates that single oral doses of Gepotidacin (GSK2140944), a novel triazaacenaphthylene antibiotic, achieve high microbiological cure rates for uncomplicated urogenital gonorrhea. The findings address a critical need for new agents active against drug-resistant Neisseria gonorrhoeae and inform advanced antibacterial research protocols.

• (5Z)-7-Oxozeaenol: Applied TAK1 Inhibition for Inflammation

  2026-06-11

  (5Z)-7-Oxozeaenol delivers precise, irreversible TAK1 inhibition, empowering researchers to dissect NF-κB and JNK/p38 MAPK pathways in cellular and animal inflammation models. This article details streamlined protocols, troubleshooting strategies, and the latest mechanistic insights for maximizing the compound's utility in advanced inflammation research.

449 records 14/30 page Previous Next First page 上5页 1112131415 下5页 Last page